Charlie Strange to Lung Diseases
This is a "connection" page, showing publications Charlie Strange has written about Lung Diseases.
Connection Strength
0.868
-
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease. Eur Respir Rev. 2017 Dec 31; 26(146).
Score: 0.506
-
Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 2010 Sep; 31(3):479-88.
Score: 0.308
-
Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration. 2006; 73(2):185-90.
Score: 0.054